These findings collectively suggest that combined monitoring of SCCA, NLR, LMR, and albumin levels can provide a more comprehensive disease assessment for cervical cancer patients from multiple dimensions, including inflammatory response, tumor burden, immune function, and nutritional status. This evidence concerns the gene ALB and neoplasm.